ePPS
Phase NA Recruiting
377 enrolled
Prospective Registry of Histotripsy for Soft Tissue Tumors
Recruiting
200 enrolled
QOLSarcoma
Phase NA Recruiting
60 enrolled
IVIM & OLINK in Sarcoma
Phase 2 Recruiting
145 enrolled
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Phase 1/2 Recruiting
27 enrolled
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
Phase NA Recruiting
51 enrolled
Retro-Ion
Phase NA Recruiting
64 enrolled
EXTREM ION
Phase NA Recruiting
42 enrolled
Phase II Trial of Lung Chemoemobolization
Phase 2 Recruiting
30 enrolled
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Phase 2 Recruiting
50 enrolled
BAL Fluid Biomarkers in Sarcoma
Phase 2 Recruiting
70 enrolled
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Recruiting
12,000 enrolled
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Phase 2 Recruiting
24 enrolled
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
Phase 2 Recruiting
50 enrolled
T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
Phase 1 Recruiting
40 enrolled
VERDI
Phase NA Recruiting
1,020 enrolled
A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
Phase 1 Recruiting
18 enrolled
PANTHR-S
Recruiting
800 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
ICGTM
Phase 2 Recruiting
110 enrolled
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Phase 1/2 Recruiting
63 enrolled
SCOPES II
Phase NA Recruiting
150 enrolled
ACTIVE-SARC
Phase NA Recruiting
40 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study
Recruiting
40 enrolled
An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
Recruiting
1,500 enrolled
CHIC-STS01
Phase 3 Recruiting
600 enrolled
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
Phase 1/2 Recruiting
98 enrolled
Iscador® P (Mistletoe) Immunotherapy for Recurrent Osteogenic Sarcoma
Phase 2 Recruiting
32 enrolled
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/2 Recruiting
90 enrolled
Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
Recruiting
50 enrolled
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
Phase 1/2 Recruiting
39 enrolled
GISAR
Recruiting
9,000 enrolled
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
Phase 2 Recruiting
20 enrolled
SarcAblate
Phase NA Recruiting
10 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
SCANDARE
Phase NA Recruiting
1,050 enrolled
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
Phase 2 Recruiting
30 enrolled
ReLaPSe
Recruiting
100 enrolled
Hypofractionated vs Conventional Fractionated RT in Soft Tissue Sarcomas
Phase 2 Recruiting
30 enrolled
PROSARC-1
Phase 2 Recruiting
110 enrolled
PROSARC-2
Phase 2 Recruiting
40 enrolled
Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
Phase 2 Recruiting
65 enrolled
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Phase 1/2 Recruiting
139 enrolled
BRICCS
Recruiting
40 enrolled
iCaRe2
Recruiting
999,999 enrolled
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Phase 1 Recruiting
25 enrolled
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients
Recruiting
300 enrolled
MAGNATE-S
Phase 2 Recruiting
46 enrolled
Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
Phase 1 Recruiting
18 enrolled